Results of treatment of hypertension after renal transplantation: effects of converting enzyme inhibitor, angiotensin II analog, beta-blockade, and dopamine beta-hydroxylase inhibitor.
D000293:Adolescent; D000328:Adult; D000526:Alprenolol / Q000494:pharmacology*; D000804:Angiotensin II / Q000031:analogs & derivatives; D000806:Angiotensin-Converting Enzyme Inhibitors; D001794:Blood Pressure / Q000187:drug effects; D002216:Captopril / Q000494:pharmacology; D002648:Child; D003404:Creatinine / Q000097:blood; D004299:Dopamine beta-Hydroxylase / Q000037:antagonists & inhibitors; D005260:Female; D005669:Fusaric Acid / Q000494:pharmacology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D012083:Renin / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000804:Angiotensin II; D000526:Alprenolol; D002216:Captopril; D003404:Creatinine; D004299:Dopamine beta-Hydroxylase; D012083:Renin; D005669:Fusaric Acid